Engineers Gate Manager’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,607
| Closed | -$42.2K | – | 2333 |
|
|
2024
Q4 | $42.2K | Buy |
+27,607
| New | +$42.2K | ﹤0.01% | 2110 |
|
|
2024
Q3 | – | Sell |
-16,192
| Closed | -$56.7K | – | 2231 |
|
|
2024
Q2 | $56.7K | Sell |
16,192
-58,946
| -78% | -$206K | ﹤0.01% | 1806 |
|
|
2024
Q1 | $208K | Buy |
75,138
+6,719
| +10% | +$18.6K | 0.01% | 1638 |
|
|
2023
Q4 | $116K | Buy |
68,419
+46,502
| +212% | +$79.1K | ﹤0.01% | 1754 |
|
|
2023
Q3 | $22.6K | Buy |
21,917
+4,269
| +24% | +$4.4K | ﹤0.01% | 1703 |
|
|
2023
Q2 | $20.5K | Buy |
+17,648
| New | +$20.5K | ﹤0.01% | 1667 |
|
|
2022
Q3 | – | Sell |
-159,476
| Closed | -$445K | – | 1816 |
|
|
2022
Q2 | $445K | Buy |
159,476
+146,638
| +1,142% | +$409K | 0.02% | 1176 |
|
|
2022
Q1 | $73K | Buy |
+12,838
| New | +$73K | ﹤0.01% | 1739 |
|
|
2021
Q4 | – | Sell |
-11,006
| Closed | -$118K | – | 2128 |
|
|
2021
Q3 | $118K | Buy |
+11,006
| New | +$118K | 0.01% | 1517 |
|
|
2020
Q3 | – | Sell |
-39,375
| Closed | -$579K | – | 1812 |
|
|
2020
Q2 | $579K | Sell |
39,375
-3,861
| -9% | -$56.8K | 0.03% | 880 |
|
|
2020
Q1 | $508K | Buy |
43,236
+29,628
| +218% | +$348K | 0.04% | 751 |
|
|
2019
Q4 | $320K | Sell |
13,608
-4,319
| -24% | -$102K | 0.01% | 1230 |
|
|
2019
Q3 | $332K | Buy |
+17,927
| New | +$332K | 0.02% | 964 |
|
|
2019
Q2 | – | Sell |
-34,300
| Closed | -$838K | – | 1244 |
|
|
2019
Q1 | $838K | Buy |
+34,300
| New | +$838K | 0.05% | 489 |
|